SCHEMBL14010995

SCHEMBL14010995

O=C(CCc1c(O)c2ccccc2oc1=O)Oc1ccccc1CO

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 4/20 0.52
ALDH1A1 P00352 2/20 0.52
LMNA P02545 2/20 0.52
TP53 P04637 2/20 0.52
TSHR P16473 2/20 0.52
MAPK1 P28482 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ABCB11 O95342 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
PDE4D Q08499 1/20 0.52
PCSK7 Q16549 1/20 0.52
GPR35 Q9HC97 1/20 0.52
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
VKORC1 Q9BQB6 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7356922 0.79 NQO1 (0.52) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL1647996 0.78 ALDH1A1 (0.61) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL1649087 0.77 NQO1 (0.67) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL8945469 0.76 NQO1 (0.49) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL1647666 0.76 LMNA (0.52) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL8945436 0.74 VKORC1 (0.55) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL7379480 0.74 VKORC1 (0.55) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL8945430 0.74 NPC1 (0.62) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL8934502 0.73 NQO1 (0.69) NQO1ALDH1A1LMNATP53TSHR
SCHEMBL1649884 0.73 NQO1 (0.57) NQO1ALDH1A1LMNATP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319025-A1 Therapeutic and Diagnostic Methods Dependent on CYP2A Enzymes NICOGEN, INC. (CA) 2008-12-25 US disclosed
US-7371414-B2 Therapeutic and diagnostic methods dependent on CYP2A enzymes NICOGEN, INC. (CA) 2008-05-13 US disclosed